Logo image of TMPO

TEMPO AUTOMATION HOLDINGS IN (TMPO) Stock Fundamental Analysis

NASDAQ:TMPO - Nasdaq - US88024M1080 - Common Stock - Currency: USD

0.0461  -0.04 (-44.46%)

After market: 0.0389 -0.01 (-15.62%)

Fundamental Rating

1

TMPO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of TMPO have multiple concerns. TMPO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year TMPO has reported negative net income.
In the past year TMPO has reported a negative cash flow from operations.
TMPO Yearly Net Income VS EBIT VS OCF VS FCFTMPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -50M -100M

1.2 Ratios

With a Return On Assets value of -375.34%, TMPO is not doing good in the industry: 97.58% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -375.34%
ROE N/A
ROIC N/A
ROA(3y)-234.99%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TMPO Yearly ROA, ROE, ROICTMPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 200 -200 400 -400 -600

1.3 Margins

With a Gross Margin value of 23.13%, TMPO perfoms like the industry average, outperforming 42.74% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for TMPO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TMPO Yearly Profit, Operating, Gross MarginsTMPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -200 -400 -600 -800 -1K

0

2. Health

2.1 Basic Checks

TMPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TMPO has been reduced compared to 1 year ago.
The debt/assets ratio for TMPO is higher compared to a year ago.
TMPO Yearly Shares OutstandingTMPO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 5M 10M 15M 20M 25M
TMPO Yearly Total Debt VS Total AssetsTMPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -35.25, we must say that TMPO is in the distress zone and has some risk of bankruptcy.
TMPO has a worse Altman-Z score (-35.25) than 95.97% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -35.25
ROIC/WACCN/A
WACC37.37%
TMPO Yearly LT Debt VS Equity VS FCFTMPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.18 indicates that TMPO may have some problems paying its short term obligations.
TMPO's Current ratio of 0.18 is on the low side compared to the rest of the industry. TMPO is outperformed by 97.58% of its industry peers.
A Quick Ratio of 0.12 indicates that TMPO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.12, TMPO is doing worse than 97.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.12
TMPO Yearly Current Assets VS Current LiabilitesTMPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 10M 20M 30M 40M

3

3. Growth

3.1 Past

TMPO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2805.32%.
EPS 1Y (TTM)-2805.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-362.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, TMPO will show a very strong growth in Earnings Per Share. The EPS will grow by 26.95% on average per year.
TMPO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 63.86% yearly.
EPS Next Y75.02%
EPS Next 2Y35.53%
EPS Next 3Y26.95%
EPS Next 5YN/A
Revenue Next Year78.05%
Revenue Next 2Y69.09%
Revenue Next 3Y63.86%
Revenue Next 5YN/A

3.3 Evolution

TMPO Yearly Revenue VS EstimatesTMPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 10M 20M 30M 40M 50M
TMPO Yearly EPS VS EstimatesTMPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.5 -1 -1.5 -2 -2.5

1

4. Valuation

4.1 Price/Earnings Ratio

TMPO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TMPO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMPO Price Earnings VS Forward Price EarningsTMPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMPO Per share dataTMPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as TMPO's earnings are expected to grow with 26.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.53%
EPS Next 3Y26.95%

0

5. Dividend

5.1 Amount

TMPO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TEMPO AUTOMATION HOLDINGS IN

NASDAQ:TMPO (11/1/2023, 8:00:01 PM)

After market: 0.0389 -0.01 (-15.62%)

0.0461

-0.04 (-44.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-23 2023-10-23/amc
Earnings (Next)11-14 2023-11-14/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners12.87%
Ins Owner Change0%
Market Cap1.42M
Analysts82.86
Price Target3.06 (6537.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)42.81%
Min EPS beat(2)42.81%
Max EPS beat(2)42.81%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.68%
Min Revenue beat(2)-6.25%
Max Revenue beat(2)11.61%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.42
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-1.09
OCFYN/A
SpS0.18
BVpS-1.01
TBVpS-1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -375.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.13%
FCFM N/A
ROA(3y)-234.99%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.12
Altman-Z -35.25
F-Score3
WACC37.37%
ROIC/WACCN/A
Cap/Depr(3y)40.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2805.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-362.33%
EPS Next Y75.02%
EPS Next 2Y35.53%
EPS Next 3Y26.95%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year78.05%
Revenue Next 2Y69.09%
Revenue Next 3Y63.86%
Revenue Next 5YN/A
EBIT growth 1Y-580.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.53%
EBIT Next 3Y27.24%
EBIT Next 5YN/A
FCF growth 1Y-2097.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2094.96%
OCF growth 3YN/A
OCF growth 5YN/A